Engineered T cells for cancer therapy

被引:96
作者
June, Carl H. [1 ,2 ]
Maus, Marcela V. [1 ,3 ]
Plesa, Gabriela [1 ]
Johnson, Laura A. [1 ,2 ]
Zhao, Yangbing [1 ,2 ]
Levine, Bruce L. [1 ,2 ]
Grupp, Stephan A. [1 ,4 ]
Porter, David L. [1 ,3 ]
机构
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
关键词
Adoptive cell transfer; Gene transfer; Leukemia; Chimeric antigen receptor; 19th Danish Cancer Society Symposium; ADOPTIVE IMMUNOTHERAPY; ANTITUMOR-ACTIVITY; GENE-THERAPY; TOXICITY; REGRESSION; CD28; SPECIFICITY; PERSISTENCE; ACTIVATION; EXPRESSION;
D O I
10.1007/s00262-014-1568-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is now well established that the immune system can control and eliminate cancer cells. Adoptive T cell transfer has the potential to overcome the significant limitations associated with vaccine-based strategies in patients who are often immune compromised. Application of the emerging discipline of synthetic biology to cancer, which combines elements of genetic engineering and molecular biology to create new biological structures with enhanced functionalities, is the subject of this focused research review.
引用
收藏
页码:969 / 975
页数:7
相关论文
共 54 条
[1]   Different affinity windows for virus and cancer-specific T-cell receptors: Implications for therapeutic strategies [J].
Aleksic, Milos ;
Liddy, Nathaniel ;
Molloy, Peter E. ;
Pumphrey, Nick ;
Vuidepot, Annelise ;
Chang, Kyong-Mi ;
Jakobsen, Bent K. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (12) :3174-3179
[2]   Chimeric Antigen Receptor Therapy for Cancer [J].
Barrett, David M. ;
Singh, Nathan ;
Porter, David L. ;
Grupp, Stephan A. ;
June, Carl H. .
ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 :333-347
[3]   Toxicity management for patients receiving novel T-cell engaging therapies [J].
Barrett, David M. ;
Teachey, David T. ;
Grupp, Stephan A. .
CURRENT OPINION IN PEDIATRICS, 2014, 26 (01) :43-49
[4]   Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies [J].
Beatty, Gregory L. ;
Haas, Andrew R. ;
Maus, Marcela V. ;
Torigian, Drew A. ;
Soulen, Michael C. ;
Plesa, Gabriela ;
Chew, Anne ;
Zhao, Yangbing ;
Levine, Bruce L. ;
Albelda, Steven M. ;
Kalos, Michael ;
June, Carl H. .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (02) :112-120
[5]   Blockade of TGF-β Signaling Greatly Enhances the Efficacy of TCR Gene Therapy of Cancer [J].
Bendle, Gavin M. ;
Linnemann, Carsten ;
Bies, Laura ;
Song, Ji-Ying ;
Schumacher, Ton N. M. .
JOURNAL OF IMMUNOLOGY, 2013, 191 (06) :3232-3239
[6]   CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia [J].
Brentjens, Renier J. ;
Davila, Marco L. ;
Riviere, Isabelle ;
Park, Jae ;
Wang, Xiuyan ;
Cowell, Lindsay G. ;
Bartido, Shirley ;
Stefanski, Jolanta ;
Taylor, Clare ;
Olszewska, Malgorzata ;
Borquez-Ojeda, Oriana ;
Qu, Jinrong ;
Wasielewska, Teresa ;
He, Qing ;
Bernal, Yvette ;
Rijo, Ivelise V. ;
Hedvat, Cyrus ;
Kobos, Rachel ;
Curran, Kevin ;
Steinherz, Peter ;
Jurcic, Joseph ;
Rosenblat, Todd ;
Maslak, Peter ;
Frattini, Mark ;
Sadelain, Michel .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (177)
[7]   Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias [J].
Brentjens, Renier J. ;
Riviere, Isabelle ;
Park, Jae H. ;
Davila, Marco L. ;
Wang, Xiuyan ;
Stefanski, Jolanta ;
Taylor, Clare ;
Yeh, Raymond ;
Bartido, Shirley ;
Borquez-Ojeda, Oriana ;
Olszewska, Malgorzata ;
Bernal, Yvette ;
Pegram, Hollie ;
Przybylowski, Mark ;
Hollyman, Daniel ;
Usachenko, Yelena ;
Pirraglia, Domenick ;
Hosey, James ;
Santos, Elmer ;
Halton, Elizabeth ;
Maslak, Peter ;
Scheinberg, David ;
Jurcic, Joseph ;
Heaney, Mark ;
Heller, Glenn ;
Frattini, Mark ;
Sadelain, Michel .
BLOOD, 2011, 118 (18) :4817-4828
[8]   Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells [J].
Cameron, Brian J. ;
Gerry, Andrew B. ;
Dukes, Joseph ;
Harper, Jane V. ;
Kannan, Vivekanandan ;
Bianchi, Frayne C. ;
Grand, Francis ;
Brewer, Joanna E. ;
Gupta, Minnal ;
Plesa, Gabriela ;
Bossi, Giovanna ;
Vuidepot, Annelise ;
Powlesland, Alex S. ;
Legg, Alison ;
Adams, Katherine J. ;
Bennett, Alan D. ;
Pumphrey, Nicholas J. ;
Williams, Daniel D. ;
Binder-Scholl, Gwendolyn ;
Kulikovskaya, Irina ;
Levine, Bruce L. ;
Riley, James L. ;
Varela-Rohena, Angel ;
Stadtmauer, Edward A. ;
Rapoport, Aaron P. ;
Linette, Gerald P. ;
June, Carl H. ;
Hassan, Namir J. ;
Kalos, Michael ;
Jakobsen, Bent K. .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (197)
[9]   Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains [J].
Carpenito, Carmine ;
Milone, Michael C. ;
Hassan, Raffit ;
Simonet, Jacqueline C. ;
Lakhal, Mehdi ;
Suhoski, Megan M. ;
Varela-Rohena, Angel ;
Haines, Kathleen M. ;
Heitjan, Daniel F. ;
Albelda, Steven M. ;
Carroll, Richard G. ;
Riley, James L. ;
Pastan, Ira ;
June, Carl H. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (09) :3360-3365
[10]   Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia [J].
Davila, Marco L. ;
Riviere, Isabelle ;
Wang, Xiuyan ;
Bartido, Shirley ;
Park, Jae ;
Curran, Kevin ;
Chung, Stephen S. ;
Stefanski, Jolanta ;
Borquez-Ojeda, Oriana ;
Olszewska, Malgorzata ;
Qu, Jinrong ;
Wasielewska, Teresa ;
He, Qing ;
Fink, Mitsu ;
Shinglot, Himaly ;
Youssif, Maher ;
Satter, Mark ;
Wang, Yongzeng ;
Hosey, James ;
Quintanilla, Hilda ;
Halton, Elizabeth ;
Bernal, Yvette ;
Bouhassira, Diana C. G. ;
Arcila, Maria E. ;
Gonen, Mithat ;
Roboz, Gail J. ;
Maslak, Peter ;
Douer, Dan ;
Frattini, Mark G. ;
Giralt, Sergio ;
Sadelain, Michel ;
Brentjens, Renier .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)